Get Educated and Get Screened During Prostate Cancer Awareness

September is Prostate Cancer Awareness Month, a time to raise awareness about the risks of prostate cancer and encourage men to take control of their prostate health by getting their regular screenings. Prostate cancer is one of the most common cancers found in American men, second only to skin cancer. In 2020, the American Cancer […]

How To Succeed When You’ve Never Done The Job Before

Forbes Leading the third-largest COVID testing lab in the United States amid a pandemic, was not something Dr. Jon Cohen learned how to do in medical school. His career in healthcare administration and politics didn’t fully prepare him for this experience either. As Executive Chairman of BioReference Lab, Cohen had to apply a critical skill […]

Labs Struggled With Surge in Covid-Testing Demand; How One Made It Through

Wall Street Journal BioReference Labs shut down temporarily in July in a controversial move that helped it win new business and prepare for the coming flu season Technicians processed incoming Covid-19 tests at BioReference Laboratories in Elmwood Park, N.J. ELMWOOD PARK, N.J.—In early July, as coronavirus surged across the U.S., one of the nation’s biggest laboratories involved […]

OPKO Health’s BioReference Laboratories Announces New York City Schools COVID-19 Testing Program

The COVID-19 testing program will test principals, teachers and staff in preparation for a safer back-to-school environment ELMWOOD PARK, N.J., September 2, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today began testing New York City principals, teachers and other staff for COVID-19, across the five boroughs, in preparation for a safer back-to-school environment. Through a […]

Media Alert: Update on NFL COVID-19 Testing

“On August 22, BioReference Laboratories reported an elevated number of positive COVID-19 PCR test results for NFL players and personnel at multiple clubs. The NFL immediately took necessary actions to ensure the safety of the players and personnel. Our investigation indicated that these were most likely false positive results, caused by an isolated contamination during […]

OPKO Health’s BioReference Laboratories Expands Contract With Blue Cross and Blue Shield of Texas to Include All Plans and Products

ELMWOOD PARK, N.J., August 18, 2020 – BioReference Laboratories Inc., an OPKO Health Company, is pleased to announce it is now in-network with all Blue Cross and Blue Shield of Texas (BCBSTX) products, including its Health Maintenance Organization (HMO) and Medicaid lines of business. The contract includes BioReference’s subsidiary GeneDx, Inc., a full service genetics […]

OPKO Health’s GeneDx Enters into Agreement with Pediatrix Medical Group to Offer Neonatal Genomic Services

GAITHERSBURG, Md., August 12, 2020 – GeneDx, Inc., a subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), the global leader in neonatal and pediatric genetic testing, announced the entrance into an agreement with Pediatrix Medical Group (“Pediatrix”), the nation’s leading provider of maternal-fetal, and pediatric medical and surgical subspecialty physician services, to offer state-of-the-art, […]

School is Back in Session

After most schools were cancelled early last spring due to COVID-19, back to school season may be a little different this year. As you round up the notebooks and sharpen the pencils, and get the kids back to their regular classrooms, schedules and teachers, it’s also time to think about regular immunizations. Vaccination throughout childhood […]

OPKO Health’s GeneDx Adds GenomeXpress to Its Industry-Leading Clinical Genomics Portfolio

GenomeXpress is a rapid genome sequencing test, reporting results within approximately seven days GAITHERSBURG, Md., Aug. 6, 2020 /PRNewswire/ — GeneDx, Inc., a subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the launch of GenomeXpress, a rapid genome sequencing test. Verbal GenomeXpress results of pathogenic and/or likely pathogenic variants in known disease causing genes are […]